News | FDA | August 18, 2023

Kitware leveraged the cutting-edge 3D Slicer medical visualization platform to develop custom medical imaging software and provided support throughout the FDA application process 

Kitware leveraged the cutting-edge 3D Slicer medical visualization platform to develop custom medical imaging software and provided support throughout the FDA application process

August 18, 2023 — Kitware, a leader in developing innovative medical visualization software, is pleased to announce its successful collaboration with Polarean, Inc. – a medical imaging technology company and long-standing customer – and their recent FDA-approval of their lung imaging technology. 

Polarean’s XENOVIEW VDP is image processing software that analyzes a pulmonary hyperpolarized 129Xe MR image and a proton chest MR image to provide visualization and evaluation of lung ventilation in adults and pediatric patients aged 12 years and older. This image analysis platform quantifies normalized xenon intensity of a ventilated space using a pulmonary hyperpolarized 129Xe ventilation MR image and accompanying proton chest MR image. The software, developed by Kitware based on Polarean’s technology will be used by clinicians to assist in the interpretation and numerical classification of hyperpolarized 129-Xe ventilation MR images. XENOVIEW VDP was built using 3D Slicer, an open-source medical imaging software that Kitware helps develop, and provides advanced 3D image analysis and structured clinical reporting tailored to the lung images acquired by XENOVIEW MRI technology.  

The Kitware team also supported Polarean’s FDA 510(k) application through technical guidance and documentation. Dr. Kiarash Emami, VP of Technology & Applications at Polarean remarked, "We have really enjoyed working with the Kitware team along the way and found them to be an excellent partner throughout this project." 

"Polarean's milestone is truly commendable, and we at Kitware extend our warmest congratulations," expressed Dr. Andinet Enquobahrie, Senior Director of Medical Computing at Kitware. “We believe in the power of innovation and collaboration and look forward to nurturing our collaboration to reach even greater heights in the future." 

Kitware has nearly 25 years of experience developing and deploying cutting-edge solutions for medical technology companies ranging from small companies like Polarean to Fortune 500 companies. Learn how Kitware can help bring impactful and innovative medical device technology to market.  

For more information: www.kitware.com 


Related Content

News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Could the era of the empowered patient change how imaging reports are structured and presented? It’s a question on the ...

Time August 03, 2026
arrow
News | Breast Imaging

Aug. 3, 2026 — GE HealthCare has launched Invenia ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue, a ...

Time August 03, 2026
arrow
News | Breast Imaging

July 30, 2026 — DeepHealth, Inc. has received FDA 510(k) clearance for DeepHealth Breast Ultrasound1, an AI-powered ...

Time July 31, 2026
arrow
News | Cardiac Imaging

July 8, 2026 — Conavi Medical Corp. has announced the publication of a case report in the Journal of the Society for ...

Time July 15, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | PACS

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer ...

Time July 10, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
Subscribe Now